🇺🇸 FDA
Patent

US 7928096

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

granted A61PA61P15/00A61P31/00

Quick answer

US patent 7928096 (Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P15/00, A61P31/00, A61P33/00, A61P9/00